These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Zinc supplementation attenuates insulin secretory activity in pancreatic islets of the ob/ob mouse. Begin-Heick N; Dalpe-Scott M; Rowe J; Heick HM Diabetes; 1985 Feb; 34(2):179-84. PubMed ID: 3881305 [TBL] [Abstract][Full Text] [Related]
26. Persistently enhanced sensitivity of pancreatic islets from ob/ob mice to PKC-stimulated insulin secretion. Chen NG; Romsos DR Am J Physiol; 1997 Feb; 272(2 Pt 1):E304-11. PubMed ID: 9124339 [TBL] [Abstract][Full Text] [Related]
27. Naltrexone reduces weight gain, alters "beta-endorphin", and reduces insulin output from pancreatic islets of genetically obese mice. Recant L; Voyles NR; Luciano M; Pert CB Peptides; 1980; 1(4):309-13. PubMed ID: 6272240 [TBL] [Abstract][Full Text] [Related]
28. Abnormal regulation of insulin secretion in the genetically obese (ob/ob) mouse. Black M; Heick HM; Bégin-Heick N Biochem J; 1986 Sep; 238(3):863-9. PubMed ID: 3026362 [TBL] [Abstract][Full Text] [Related]
29. Adrenoceptor-mediated control of glucose homeostasis in obese hyperglycaemic (ob/ob) mice. Bailey CJ; Flatt PR Diabetes Res; 1990 Jun; 14(2):87-91. PubMed ID: 1966872 [TBL] [Abstract][Full Text] [Related]
30. Identification of beta-cell-trophin, a peptide of the pituitary pars intermedia which stimulates insulin secretion in plasma from genetically obese (ob/ob) mice. Billingham N; Beloff-Chain A; Cawthorne MA J Endocrinol; 1982 Jul; 94(1):125-30. PubMed ID: 7047665 [TBL] [Abstract][Full Text] [Related]
31. Effects of streptozotocin on glucose metabolism, insulin response, and adiposity in ob/ob mice. Batchelor BR; Stern JS; Johnson PR; Mahler RJ Metabolism; 1975 Jan; 24(1):77-91. PubMed ID: 122852 [TBL] [Abstract][Full Text] [Related]
32. Downstream regulatory element antagonistic modulator regulates islet prodynorphin expression. Jacobson DA; Cho J; Landa LR; Tamarina NA; Roe MW; Buxbaum JD; Philipson LH Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E587-95. PubMed ID: 16621893 [TBL] [Abstract][Full Text] [Related]
33. Effects of an alpha 2-adrenoceptor antagonist on glucose tolerance in the genetically obese mouse (C57BL/6J ob/ob). Saperstein R; Chapin EW; Brady EJ; Slater EE Metabolism; 1990 May; 39(5):445-51. PubMed ID: 1970847 [TBL] [Abstract][Full Text] [Related]
34. Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action. Scrocchi LA; Hill ME; Saleh J; Perkins B; Drucker DJ Diabetes; 2000 Sep; 49(9):1552-60. PubMed ID: 10969840 [TBL] [Abstract][Full Text] [Related]
35. Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse. Bahrami J; Longuet C; Baggio LL; Li K; Drucker DJ Gastroenterology; 2010 Sep; 139(3):857-68. PubMed ID: 20546737 [TBL] [Abstract][Full Text] [Related]
38. Cholinergic enhancement by pyridostigmine increases the insulin response to glucose load in obese patients but not in normal subjects. Del Rio G; Procopio M; Bondi M; Marrama P; Menozzi R; Oleandri SE; Grottoli S; Maccario M; Velardo A; Ghigo E Int J Obes Relat Metab Disord; 1997 Dec; 21(12):1111-4. PubMed ID: 9426377 [TBL] [Abstract][Full Text] [Related]
39. Effects of zinc supplementation on the plasma glucose level and insulin activity in genetically obese (ob/ob) mice. Chen MD; Liou SJ; Lin PY; Yang VC; Alexander PS; Lin WH Biol Trace Elem Res; 1998 Mar; 61(3):303-11. PubMed ID: 9533568 [TBL] [Abstract][Full Text] [Related]